We assumed that cisplatin-based chemotherapy might serve as an external stimulus that triggers GSDME-induced pyroptosis, which may play an essential role in enhancing the efficacy of anti-PD-L1 therapy in patients with SCLC. The gene discussed is CD274; the disease is small cell lung carcinoma.